These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 20663862

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, Hung SC, Chen YC, Tseng LM, Chiou SH.
    Cancer; 2011 Jul 01; 117(13):2970-85. PubMed ID: 21225866
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP, Liu Y, Zhong W, Yu D, Wen LJ, Jin CS.
    Chin Med J (Engl); 2011 Apr 01; 124(7):1055-60. PubMed ID: 21542968
    [Abstract] [Full Text] [Related]

  • 26. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM.
    Oncogene; 2009 Nov 12; 28(45):3949-59. PubMed ID: 19718046
    [Abstract] [Full Text] [Related]

  • 27. Low intensity ultrasound promotes the sensitivity of rat brain glioma to Doxorubicin by down-regulating the expressions of p-glucoprotein and multidrug resistance protein 1 in vitro and in vivo.
    Zhang Z, Xu K, Bi Y, Yu G, Wang S, Qi X, Zhong H.
    PLoS One; 2013 Nov 12; 8(8):e70685. PubMed ID: 23940624
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX, Zheng JH, Zheng ZQ, Cai JL, Ye XH, Wang C, Sun WJ, Zhou X, Lu MD, Li PH, Cai ZZ.
    World J Surg Oncol; 2014 Dec 30; 12():404. PubMed ID: 25551472
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q, Zhang X, Deng T, Gao J.
    Cell Reprogram; 2013 Apr 30; 15(2):143-50. PubMed ID: 23438193
    [Abstract] [Full Text] [Related]

  • 33. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB, Ma RJ, Wang ZK, Yang SJ, Lin XZ, Rong H, Ma Y.
    Mol Cell Biochem; 2011 Mar 30; 349(1-2):149-57. PubMed ID: 21110069
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
    J Neurosurg; 2011 Mar 30; 114(3):651-62. PubMed ID: 21054139
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
    Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS.
    Mol Med; 2011 Mar 30; 17(1-2):103-12. PubMed ID: 20957337
    [Abstract] [Full Text] [Related]

  • 39. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
    Zhang B, Sun J, Yu SP, Chen C, Liu B, Liu ZF, Ren BC, Ming HL, Yang XJ.
    Chin Med J (Engl); 2012 Dec 30; 125(24):4344-8. PubMed ID: 23253699
    [Abstract] [Full Text] [Related]

  • 40. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells.
    Wei Y, Jiang Y, Zou F, Liu Y, Wang S, Xu N, Xu W, Cui C, Xing Y, Liu Y, Cao B, Liu C, Wu G, Ao H, Zhang X, Jiang J.
    Proc Natl Acad Sci U S A; 2013 Apr 23; 110(17):6829-34. PubMed ID: 23569237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.